Theranos directors trusted Elizabeth Holmes more than their own eyesElizabeth Holmes, Theranos’ CEO and the world’s youngest self-made female billionaire, in an interview on September 29, 2015. (Photo by David Orrell/CNBC/NBCU, Photo Bank via Getty Images.) (credit: Getty Images | CNBC)
When former US Secretary of State George Shultz underwent a Theranos blood test, it involved a standard vein draw—not the company’s proprietary finger prick blood collection.

Though at the time Theranos claimed to only use its proprietary testing, the discrepancy didn’t bother Shultz, then a member of the company’s board of directors.
In fact, according to newly unsealed court documents reported by The Wall Street Journal, he continued to believe that the company could and did use its own technology for all blood testing.
“There would be some, you know, excuse about why they needed to take a venous draw for him, but you know, for everyone else it was a finger prick.

And, he continued to buy into that,” Shultz’s grandson, Tyler, a former Theranos employee and whistleblower, testified.
Regulators and media reports revealed last year that Theranos used commercial equipment for most of its testing and had critical technical problems with its own technology.
Read 6 remaining paragraphs

Leave a Reply